WhatsApp +86 130 1285 6649
TRISANA MEDGUIDEFOR MEDICAL TOURISM IN CHINA
Home / Medical Care in China / Cardio-Cerebrovascular / Mitral regurgitation

Medical Care in China

Mitral regurgitation
Treatment in China

Provide a clear and complete coordinated pathway from expert assessment to treatment and rehabilitation.

Get a Care Plan and Cost Estimate
Internal-surgical collaboration‌Comprehensive selection of medical, surgical, and interventional treatments.
Complex heart diseasescover coronary artery disease, valvular heart disease, and structural heart disease.
Major vessel diagnosis and treatmentinvolves professional assessment of diseases of the aorta and other major blood vessels.
Severe Illness Treatment SupportPossesses comprehensive treatment capabilities for cardiovascular critical illnesses.

Condition Guide

About Mitral regurgitation

Understand the condition, common triggers and treatment options that may require specialist assessment.

Disease Introduction

Mitral regurgitation is an incomplete closure of the "valve" between the left atrium and left ventricle, causing blood to flow back into the atrium during cardiac contraction. Early symptoms may be asymptomatic, gradually progressing to shortness of breath on exertion, chest tightness, nocturnal awakenings with dyspnea, leg swelling, and fatigue. It is classified into primary (due to valvular disease itself) and secondary (due to cardiac enlargement or atrial fibrillation causing valvular annulus dilation). The general principle of treatment is to administer heart failure medications effectively for secondary mitral regurgitation, while for severe primary mitral regurgitation, early evaluation for repair or replacement is crucial to avoid further damage to cardiac function.

Cutting-edge high-precision diagnostic and treatment technologies

  1. Domestic mitral valve clips approved : Keke's transcatheter mitral valve repair system was approved by the NMPA in May 2025; Yingmai Medical and Shanghai Shenqi's transcatheter mitral valve clip systems were approved in March and April 2026, respectively, for surgically high-risk, anatomically appropriate degenerative regurgitation patients.
  2. Domestic production of edge-to-edge repair : The domestically produced transfemoral mitral valve edge-to-edge repair system DragonFly has been approved for marketing. The DRAGONFLY-DMR study showed good efficacy and safety in 120 high-risk patients with moderate to severe mitral regurgitation.
  3. Advancement of surgical timing according to guidelines : The 2025 ESC/EACTS Valve Guidelines recommend surgical mitral valve repair for patients with low-risk, asymptomatic, severe primary regurgitation who meet at least three of the following criteria: atrial fibrillation, resting pulmonary artery systolic blood pressure greater than 50 mmHg, left atrial enlargement, and moderate to severe secondary tricuspid regurgitation.
  4. Classification of secondary regurgitation : The 2025 guidelines for the first time clearly state that for atrial secondary regurgitation, mitral valve surgery combined with atrial fibrillation ablation and left atrial appendage occlusion can be performed on the basis of optimal drug therapy. For those who are not suitable for surgery, TEER can be considered. The indications for TEER for ventricular secondary regurgitation have been strengthened.
  5. Minimally invasive surgery gains recognition : The 2025 guidelines clearly state that minimally invasive mitral valve surgery can be considered in experienced centers to shorten hospital stays, accelerate recovery, and provide a surgical repair pathway for those who are unwilling or unsuitable for open-heart surgery.
 

Care Overview

Mitral regurgitation Treatment in China

The medical team will develop a personalized protocol based on the pathology type, stage, genetic test, previous treatment history, and the patient's physical condition.

Network of partner hospitals

Recommended Hospitals

Selected leading medical centers with strong specialties and international patient services.

Fuwai Hospital, Chinese Academy of Medical Sciences
Fuwai Hospital, Chinese Academy of Medical Sciences logo
Beijing · Partner Hospital

Fuwai Hospital, Chinese Academy of Medical Sciences

Organ TransplantCardio-Cerebrovascular

The hospital is home to the National Center for Cardiovascular Diseases and is a national-level tertiary-grade Class A cardiovascular disease specialist hospital. It has consistently ranked first in the nation for cardiovascular disease in the Fudan University specialist rankings for many years. The hospital houses national-level platforms such as the National Key Laboratory of Cardiovascular Diseases and the National Clinical Research Center for Cardiovascular Diseases, and was among the first batch of national medical centers to receive national support. In 2011, it performed over 10,000 internal and surgical procedures, becoming the world's largest heart disease treatment center. For 13 consecutive years, the 30-day mortality rate for cardiac surgery has remained below 1%, maintaining an internationally leading level.

Year Founded
1956
Beds
1300
West China Hospital of Sichuan University
West China Hospital of Sichuan University logo
Chengdu · Partner Hospital

West China Hospital of Sichuan University

RehabilitationOrgan TransplantRare & Complex DiseasesOncologyGastroenterologyCardio-CerebrovascularNeurologyUrologyInternal MedicineSurgeryThoracicHepatobiliaryOrthopedics

The hospital is among the first batch of national medical center construction units and a pilot hospital for high-quality development jointly built by the national and provincial governments. It has established a national medical center for mental illness and two national regional medical centers. The hospital has 43 national key clinical specialties, ranking first among hospitals in China; its clinical medicine ESI ranking is in the top 0.252‰ globally. In the Fudan University version of the China Hospital Ranking, the hospital's comprehensive strength has ranked among the top three in China for many consecutive years (ranking second in the country for 11 consecutive years). Its anesthesiology department ranks first in the country, and many other specialties such as radiology, pathology, urology, ultrasound medicine, and geriatrics are among the top in the country. More than 10 specialties in the hospital are ranked among the top three in the country, and nearly 30 specialties are ranked among the top ten in the country.

Year Founded
1982
Beds
4900
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology logo
Wuhan · Partner Hospital

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

HematologyCardio-CerebrovascularUrology

The hospital ranks 9th nationwide in the Fudan University China Hospital Specialty Ranking, making it one of the strongest hospitals in Central China. Its specialties, including heart transplantation, hematology, ultrasound, nuclear medicine, anesthesiology, and cardiovascular surgery, are among the top in the country. In particular, its nuclear medicine department has consistently ranked among the top two in Fudan University's specialty rankings for many years, and its heart transplant volume has ranked first in the country for many consecutive years. The hospital is a national drug clinical trial institution and a national stem cell clinical research institution, boasting strong research capabilities.

Year Founded
1866
Beds
6000

Leading Specialists

Trusted Expertise Across Leading Specialties

He Yong

He Yong

Deputy Director of Cardiology, Head of Coronary Artery Disease Group, Chief Physician

Cardio-Cerebrovascular

Research areas : interventional treatment of complex and high-risk coronary arteries; intravascular coronary imaging (IVUS); chronic occlusive disease (CTO). Cutting-edge technologies: The first complex high-risk PCI in China supported by a domestically produced transcatheter left ventricular pump assist device; the first in Southwest China to carry out complex coronary interventions and high-speed rotational atherectomy under intravascular ultrasound guidance; CTO retrograde interventional treatment and

West China Hospital of Sichuan University logo Affiliated Hospital West China Hospital of Sichuan University
Fu Hua

Fu Hua

Chief Physician, Doctoral Supervisor | Head of the Arrhythmia Subspecialty Group

Cardio-Cerebrovascular

Research areas: atrial fibrillation, ventricular arrhythmias, complex tachyarrhythmias; Cutting-edge technologies: 3D mapping radiofrequency ablation, pulsed electric field ablation, one-stop surgery for atrial fibrillation (ablation + left atrial appendage occlusion); Academic Highlights: Deputy Head of the Left Atrial Appendage Occlusion Group of the Chinese Society of Cardiac Electrophysiology and Pacing; specializes in ablation of ventricular tachycardia in organic heart disease, has presided over mul

West China Hospital of Sichuan University logo Affiliated Hospital West China Hospital of Sichuan University
Song Lei

Song Lei

Deputy Director of the Coronary Artery Disease Center, specializing in intravascular imaging and QFR

Cardio-Cerebrovascular

Research areas: Coronary artery disease and complex coronary interventional treatment, intravascular imaging and physiology of the coronary arteries. Cutting-edge technology: Co-first author of the FAVOR III China study published in *The Lancet* (impact factor 207), confirming that QFR-guided coronary intervention can significantly improve prognosis. Invited by *The Lancet* as the sole author from China to participate in writing a major global report on "Ischemic Heart Disease". Drafted the National Healt

Fuwai Hospital, Chinese Academy of Medical Sciences logo Affiliated Hospital Fuwai Hospital, Chinese Academy of Medical Sciences
Angie

Angie

Professor, Doctoral Supervisor, Department Head

Cardio-Cerebrovascular

- Research areas: Congenital heart disease surgery, heart transplantation, end-stage heart failure surgery; - Core technologies: Complex congenital heart disease correction in infants and young children, heart transplantation; - Areas of expertise: Various complex congenital heart diseases, dilated cardiomyopathy, and end-stage heart failure; - Academic Value: President of the Cardiovascular Surgery Branch of the Sichuan Provincial Medical Association, Standing Committee Member of the Congenital Heart Dis

West China Hospital of Sichuan University logo Affiliated Hospital West China Hospital of Sichuan University
Wu Zhong

Wu Zhong

Professor, Doctoral Supervisor, Deputy Director of Department (Academic Leader of the Coronary Artery Surgery and Chronic Pulmonary Embolism Surgery Subspecialty)

Cardio-Cerebrovascular

- Research areas: aortic disease, chronic thromboembolic pulmonary hypertension; coronary artery bypass grafting for coronary heart disease; surgical treatment of chronic thromboembolic pulmonary hypertension (CTEPH); valvular heart disease, aortic aneurysm, chronic atrial fibrillation. - Core technologies: Sun's procedure for aortic dissection, coronary artery bypass grafting; pulmonary endarterectomy (PEA) - first to be routinely performed in Southwest China, filling the technological gap in West China

West China Hospital of Sichuan University logo Affiliated Hospital West China Hospital of Sichuan University
Sun Xiaogang

Sun Xiaogang

Aortic Surgery and Neuroprotection

Cardio-Cerebrovascular

Research areas: Surgical clinical and basic research on aortic diseases, with a focus on treatment systems for the root of type A aortic dissection, repair strategies for bicuspid aortic valve malformation, and new paradigms for the treatment of the neurological system in aortic arch surgery. Cutting-edge technology: In 2017, the institute pioneered the application of aortic balloon occlusion technology to total aortic arch replacement and stent elephant trunk surgery, shortening the deep hypothermic circ

Fuwai Hospital, Chinese Academy of Medical Sciences logo Affiliated Hospital Fuwai Hospital, Chinese Academy of Medical Sciences

Patient Stories

See the Next Step Through Patient Journeys

Lower Extremity Arteriosclerosis Obliterans - A Masterpiece for Unblocking the CASE 01
PATIENT JOURNEY

Lower Extremity Arteriosclerosis Obliterans - A Masterpiece for Unblocking the "Silent Killer"

HematologyCardio-Cerebrovascular

Patient records Name: Carlos Silva Age: 70 Nationality: Brazil (São Paulo) Diagnosis: Lower extremity arteriosclerosis obliterans (Rutherford grade 4, long segment occlusion of the left superficial femoral artery, rest pain) Treatment Hospital: Department of Vascular Surgery, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine Mr. Carlos is a passionate samba dancer who, even in his seventies, still enjoys swaying to the music on the streets of Rio. However, for the past six mo

View case details →
Severe Stenosis of the M1 Segment of the Right Middle Cerebral Artery - Reconstructing the Brain's CASE 02
PATIENT JOURNEY

Severe Stenosis of the M1 Segment of the Right Middle Cerebral Artery - Reconstructing the Brain's "Bridge of Life"

Cardio-Cerebrovascular

Patient records Name: Emily Brown Age: 42 Nationality: British (London) Diagnosis: Severe stenosis (90%) in the M1 segment of the right middle cerebral artery, recurrent transient ischemic attacks (TIAs). Treatment Hospital: Xuanwu Hospital, Capital Medical University—Department of Neurosurgery/Interventional Radiology Emily is a financial analyst in London, her world a tapestry of precise numbers and rapid decision-making. However, starting a year ago, her brain began to frequently "malfunction." She wo

View case details →
Acute Stanford Type A Aortic Dissection - Defused a CASE 03
PATIENT JOURNEY

Acute Stanford Type A Aortic Dissection - Defused a "Time Bomb" Inside the Body

Cardio-Cerebrovascular

Patient records Name: David Chen Age: 52 Nationality: Vietnamese Diagnosis: Acute Stanford type A aortic dissection (DeBakey type I, involving the ascending aorta, aortic arch, and descending aorta, complicated by severe aortic regurgitation) Treatment Hospital: Fuwai Hospital, Chinese Academy of Medical Sciences (National Center for Cardiovascular Diseases) — Vascular Surgery Center David now jogs 5 kilometers along the Vancouver beach every morning. He says that with each heartbeat, he feels grateful t

View case details →

Service Process

A clear, coordinated process for efficient cross-border care

  1. 01

    Pre-Visit Services

    Contact us for help organising and translating medical records, planning consultations, and finding suitable hospitals and specialists.

  2. 02

    Remote Consultations

    A remote consultation helps establish an initial approach to diagnosis and treatment, with a cost estimate available within 48 hours.

  3. 03

    Travel Arrangements

    We assist with visa applications, book flights and hotel or apartment accommodation, and arrange airport pick-up, private transport and check-in.

  4. 04

    Comprehensive Support in China

    We accompany you to medical appointments and provide interpreting services, help arrange specialist consultations or surgery, assist with hospital admission and discharge, and help settle medical bills.

  5. 05

    Post-Visit Services

    We assist with notarisation of medical expense documents, airport drop-off, organisation and translation of medical records, remote rehabilitation guidance, and coordination of international referrals.

Next Step

Get a Care Plan
and Cost Estimate.

Tell us about your diagnosis and needs, and our team will help screen the right hospital and explain the next steps.

Email:goldentcm@163.com

Get a Care Plan and Estimate

Once you submit your information, a member of our support team will reach out to you within one business day.